Form 8-K - Current report:
SEC Accession No. 0001213900-25-013787
Filing Date
2025-02-14
Accepted
2025-02-14 07:30:36
Documents
15
Period of Report
2025-02-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0231153-8k_incannex.htm   iXBRL 8-K 27069
2 PRESS RELEASE OF INCANNEX HEALTHCARE INC., DATED FEBRUARY 14, 2025 ea023115301ex99-1_incannex.htm EX-99.1 71604
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2915
  Complete submission text file 0001213900-25-013787.txt   289370

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ixhl-20250214.xsd EX-101.SCH 3024
5 XBRL LABEL FILE ixhl-20250214_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ixhl-20250214_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0231153-8k_incannex_htm.xml XML 3787
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 25623222
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)